QS Rank:

2

Imperial College London

London
,United Kingdom

Program Name
PhD in Antibody-Drug-Conjugates

Deadline
January 30th, 2026
Overview
Title: Cysteine-selective bioconjugation warheads for ADCs/nInstitution: Imperial College London, Institute of Chemical Biology/nThis project is co-sponsored by the EPSRC CDT in Chemical Biology and GSK./nAntibody-drug-conjugates (ADCs) are promising therapeutic modalities enabling the selective delivery of highly potent payloads to a disease tissue./nProgram type: PhD Research Project/nFunding: Funded PhD Project (Students Worldwide)
Ranking
#20
US World and News Report
#12
The World University Rankings
#2
QS World University Rankings
Class Profile
Application Requirements
Here's everything you need to know to ensure a complete and competitive application—covering the key documents and criteria for a successful submission.
Application Deadlines
| Default | |
|---|---|
| winter | Jan 30, 2026 |
Ready to elevate your study abroad journey?
Book a call with us now and take the first step towards your global future!



